The effect of TGF-β2 on CCl4-induced liver fibrosis in Balb/c mice was determined by tail vein injection of active TGF-β2 for 4 weeks after CCl4 induction (Fig. 8F). The gene discussed is TGFB2; the disease is Hepatic fibrosis.